Podcast Description:

Navigating the complexities of systemic anticancer therapy (SACT) demands meticulous attention to detail, especially when it comes to prescribing. In this episode of the Irish Haematology Oncology Podcast, join your host Eoin Tabb as he delves into the critical aspects of safe prescribing practices for SACT. We'll explore the reasons why SACT prescribing is considered high-risk, the essential steps involved in the prescribing process for both first and subsequent cycles, and the key components of a comprehensive treatment plan. We'll also discuss the legal requirements and prescribing standards, strategies to mitigate errors, and the unique safety challenges associated with oral anticancer medicines (OAMs). Whether you're at the beginning of your career or seeking a refresher, this episode will equip you with the knowledge and insights to ensure the safe and effective administration of these powerful medications to your patients.

Takeaways

• DPYD testing is crucial for personalized cancer treatment.
• SACT medications have a narrow therapeutic index.
• Creating a treatment plan requires meaningful patient conversations.
• Clear communication among healthcare professionals is essential.
• Legal standards in prescribing protect patients and prescribers.
• Ambiguity in prescriptions can lead to serious errors.
• Pharmacists play a critical role in patient safety.
• Oral anti-cancer medicines come with unique safety challenges.
• Regular reassessment of patient fitness for treatment is necessary.
• Safe prescribing is a shared responsibility among all healthcare providers.

Feedback Form

IIOP Example CPD for Pharmacists